Back to R2 link
Top Industry News
- FDA Guidance on Potency Assurance for Cellular and Gene Therapy Products
- FDA Guidance on Quality Considerations for Topical Ophthalmic Drug Products
- Swissmedic New Guidance on the Import of a Human Medicinal Product in Accordance with Article 14 Paragraphs 2 and 3 TPA (Parallel Import)
- PMDA Update on Clinical Trials Conducted from a Humanitarian Perspective
- PMDA Update Information on Institutional Review Board (IRB) Registration
- PMDA Reporting System for Side Effects During Clinical Trials of Pharmaceuticals (Drugs)
- PMDA Update on Status of Response to PDG Harmonized Documents at the Japanese Bureau (Test methods, etc.)
- MHRA Guidance on Medicines: Reclassify your Product
- The FDA Releases Revised Guidelines on Reporting Serious Adverse Events for Cosmetic Products.
- The FDA Releases Conclusive Guidance Regarding the Registration and Listing Procedures for Cosmetic Product Facilities and Products.
- SFDA Guidance for Medication Error Reporting
- FDA Announces Launch of Cosmetics Direct for Electronic Registration and Listing of Cosmetic Product Facilities and Products
- The FDA Releases a Guide on Structured Product Labeling (SPL) Implementation, Featuring Validation Procedures For Registering Cosmetic Product Facilities and Listing Products.
- Inclusion of Millet and Millet Flour in the CAA
- FDA Provides Update on Actions to Strengthen the Safety and Supply Chain Resiliency of Infant Formula
- Notice of Modification to the List of Permitted Coloring Agents to Extend the Use of Allura Red to Fruit Flavored Beer
- 121 CFR Sec. 173 Secondary direct Food Additives Permitted in Food for Human Consumption